Immune cells once thought to be innocent bystanders in cystic fibrosis may hold the key to stopping patients’ fatal lung disease. New findings show that white blood cells called neutrophils respond strongly to conflicting signals from cystic fibrosis patients’ lungs, setting up a molecular fracas that may explain the patients’ severe lung damage.